6-K ·Filed Oct 19, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor the October 22 fireside chat for any updates on Phase 3 trial initiation timeline or regulatory interactions, but this filing alone provides no new catalyst.
Latest settled — T+5d
ATHE ▼ -14.40% at T+5d
NEUTRAL call -14.40% · α vs SPY -14.26% · entry $2.43 → $2.08
T+1d
-2.47%
call -2.47% · α -2.80%
$2.37
settled 7d ago
T+5d
-14.40%
call -14.40% · α -14.26%
$2.08
settled yesterday
T+20d
Pending
in 20d
T+60d
Pending
in 3mo
Price Chart
Loading chart...
Executive Summary
Alterity Therapeutics announced that CEO David Stamler will participate in a fireside chat at the Craig-Hallum Virtual Biotech Catalyst Conference on October 22, 2026. This is a routine investor relations event with no new material financial or clinical data disclosed.
Key Facts
- CEO David Stamler to present at Craig-Hallum Virtual Biotech Catalyst Conference on October 22, 2026 at 2:30 p.m. ET
- No new financial results, clinical data, or guidance provided in the filing
- Company is preparing to initiate a Phase 3 pivotal trial for ATH434 in Multiple System Atrophy (MSA)
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No new material information — stock may trade on existing sentiment and cash runway concerns
- Conference participation is standard practice and unlikely to move the stock without new data
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001437749-26-032871 |
| Exhibit: ex_1027491.htm | 0001437749-26-032871 |
| Document: 0001437749-26-032871-index-headers.html | 0001437749-26-032871 |
| Document: 0001437749-26-032871-index.html | 0001437749-26-032871 |
| Document: 0001437749-26-032871.txt | 0001437749-26-032871 |
42 reports for ATHE
67% Hit rate @ T+60 Went positive at some point 10 of 10 best @ T+20▲ +27.97%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (+0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 23, 2026 4d ago | 6-K | $2.09 | awaiting T+60 | — | $2.08 (−0.48%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 21, 2026 6d ago | 6-K | $2.39 | awaiting T+60 | — | $2.08 (−12.97%) |
Oct 19, 2026 8d ago | 6-K | $2.43 | awaiting T+60 | — | $2.08 (−14.40%) |
Oct 9, 2026 18d ago | 6-K | $3.12 | awaiting T+60 | — | $2.08 (−33.33%) |
Oct 5, 2026 22d ago | Press Release | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Oct 5, 2026 22d ago | 6-K | $3.22 | awaiting T+60 | — | $2.08 (−35.40%) |
Sep 25, 2026 4w ago | 6-K | $3.67 | awaiting T+60 | — | $2.08 (−43.32%) |
Showing 10 of 42
US Market Status
Market Closed — Opens in 1h 1m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers